Publication Information

{'id': 'https://openalex.org/W2809097515', 'doi': 'https://doi.org/10.1212/wnl.88.16_supplement.s31.006', 'title': 'Comparison of Natalizumab vs Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience (S31.006)', 'display_name': 'Comparison of Natalizumab vs Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience (S31.006)', 'publication_year': 2017, 'publication_date': '2017-04-18', 'ids': {'openalex': 'https://openalex.org/W2809097515', 'doi': 'https://doi.org/10.1212/wnl.88.16_supplement.s31.006', 'mag': '2809097515'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.88.16_supplement.s31.006', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081495152', 'display_name': 'Brandi Vollmer', 'orcid': 'https://orcid.org/0000-0002-0593-9012'}, 'institutions': [{'id': 'https://openalex.org/I2802654978', 'display_name': 'The Medical Center of Aurora', 'ror': 'https://ror.org/04qw37741', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802654978', 'https://openalex.org/I4210120438']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brandi Vollmer', 'raw_affiliation_strings': ['Department of Neurology Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology Aurora CO United States', 'institution_ids': ['https://openalex.org/I2802654978']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103060239', 'display_name': 'Kavita Nair', 'orcid': 'https://orcid.org/0000-0002-2442-2537'}, 'institutions': [{'id': 'https://openalex.org/I921990950', 'display_name': 'University of Colorado Denver', 'ror': 'https://ror.org/02hh7en24', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I921990950']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kavita Nair', 'raw_affiliation_strings': ['Skagg’s School of Pharmacy and Pharmaceutical Sciences, University of Colorado Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Skagg’s School of Pharmacy and Pharmaceutical Sciences, University of Colorado Aurora CO United States', 'institution_ids': ['https://openalex.org/I921990950']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007533038', 'display_name': 'Stefan Sillau', 'orcid': 'https://orcid.org/0000-0002-8691-3139'}, 'institutions': [{'id': 'https://openalex.org/I2802654978', 'display_name': 'The Medical Center of Aurora', 'ror': 'https://ror.org/04qw37741', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802654978', 'https://openalex.org/I4210120438']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stefan Sillau', 'raw_affiliation_strings': ['Department of Neurology Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology Aurora CO United States', 'institution_ids': ['https://openalex.org/I2802654978']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010784347', 'display_name': 'John Corboy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802654978', 'display_name': 'The Medical Center of Aurora', 'ror': 'https://ror.org/04qw37741', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802654978', 'https://openalex.org/I4210120438']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Corboy', 'raw_affiliation_strings': ['Department of Neurology Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology Aurora CO United States', 'institution_ids': ['https://openalex.org/I2802654978']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025759103', 'display_name': 'Timothy R. Vollmer', 'orcid': 'https://orcid.org/0000-0003-2750-9985'}, 'institutions': [{'id': 'https://openalex.org/I2802654978', 'display_name': 'The Medical Center of Aurora', 'ror': 'https://ror.org/04qw37741', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802654978', 'https://openalex.org/I4210120438']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Timothy Vollmer', 'raw_affiliation_strings': ['Department of Neurology Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology Aurora CO United States', 'institution_ids': ['https://openalex.org/I2802654978']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5064205043', 'display_name': 'Enríque Alvarez', 'orcid': 'https://orcid.org/0000-0001-5854-9643'}, 'institutions': [{'id': 'https://openalex.org/I2802654978', 'display_name': 'The Medical Center of Aurora', 'ror': 'https://ror.org/04qw37741', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802654978', 'https://openalex.org/I4210120438']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Enrique Alvarez', 'raw_affiliation_strings': ['Department of Neurology Aurora CO United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology Aurora CO United States', 'institution_ids': ['https://openalex.org/I2802654978']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': '88', 'issue': '16_supplement', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13385', 'display_name': 'Infectious Diseases and Mycology', 'score': 0.962, 'subfield': {'id': 'https://openalex.org/subfields/3404', 'display_name': 'Small Animals'}, 'field': {'id': 'https://openalex.org/fields/34', 'display_name': 'Veterinary'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13385', 'display_name': 'Infectious Diseases and Mycology', 'score': 0.962, 'subfield': {'id': 'https://openalex.org/subfields/3404', 'display_name': 'Small Animals'}, 'field': {'id': 'https://openalex.org/fields/34', 'display_name': 'Veterinary'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10137', 'display_name': 'Multiple Sclerosis Research Studies', 'score': 0.9593, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11827', 'display_name': 'Polyomavirus and related diseases', 'score': 0.9576, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/natalizumab', 'display_name': 'Natalizumab', 'score': 0.9854349}, {'id': 'https://openalex.org/keywords/dimethyl-fumarate', 'display_name': 'Dimethyl fumarate', 'score': 0.96129555}], 'concepts': [{'id': 'https://openalex.org/C2781004633', 'wikidata': 'https://www.wikidata.org/wiki/Q386119', 'display_name': 'Natalizumab', 'level': 3, 'score': 0.9854349}, {'id': 'https://openalex.org/C2776036978', 'wikidata': 'https://www.wikidata.org/wiki/Q425137', 'display_name': 'Fingolimod', 'level': 3, 'score': 0.9829761}, {'id': 'https://openalex.org/C2776819417', 'wikidata': 'https://www.wikidata.org/wiki/Q418123', 'display_name': 'Dimethyl fumarate', 'level': 3, 'score': 0.96129555}, {'id': 'https://openalex.org/C2780640218', 'wikidata': 'https://www.wikidata.org/wiki/Q8277', 'display_name': 'Multiple sclerosis', 'level': 2, 'score': 0.88294375}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6604847}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.3873429}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.18903977}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.88.16_supplement.s31.006', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.71, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4233957026', 'https://openalex.org/W3183961786', 'https://openalex.org/W3089077454', 'https://openalex.org/W2766897926', 'https://openalex.org/W2401168467', 'https://openalex.org/W2343984847', 'https://openalex.org/W2338099154', 'https://openalex.org/W2169569625', 'https://openalex.org/W2053484098', 'https://openalex.org/W1994801541'], 'abstract_inverted_index': {'Objective:': [0], 'Compare': [2], 'two': [3, 98, 151, 293], 'year': [4], 'discontinuation': [5, 215], 'rates': [6, 289], 'and': [7, 11, 69, 83, 101, 119, 140, 148, 161, 173, 191, 196, 209, 228, 242, 247, 253, 258, 263, 268, 271, 299, 346, 365, 390, 407, 441, 459, 470], 'efficacy': [8, 313], 'of': [9, 31, 41, 64, 94, 116, 158, 180, 207, 212, 226, 231], 'fingolimod(FTY)': [10], 'dimethyl': [12], 'fumarate(DMF)': [13], 'to': [14, 128, 323, 352], 'natalizumab(NTZ).': [15], 'Background:': [17], 'Limited': [19], 'comparative': [20], 'effectiveness': [21], 'data': [22, 34, 75, 108], 'exists': [23], 'with': [24, 284, 333, 362, 401], 'conflicting': [25], 'reports.': [26], 'This': [27], 'is': [28], 'a': [29, 44, 155, 175, 445], 'continuation': [30], 'previously': [32], 'presented': [33], 'for': [35, 107, 111, 183, 214, 235, 250, 302, 331, 360, 378, 399], 'FTY': [36, 201, 241, 285], 'vs': [37], 'DMF,': [38], 'through': [39], 'addition': [40], 'NTZ': [42, 55, 149, 199, 219, 237, 254, 310], 'as': [43, 444], 'third': [45], 'arm.': [46], 'Design/Methods:': [48], 'Patients': [50, 153], 'prescribed': [51], 'FTY,': [52, 146, 194, 251], 'DMF': [53, 147, 195, 221, 243, 252], 'or': [54], 'at': [56, 62, 122, 216], 'the': [57, 92, 132, 291], 'Rocky': [58], 'Mountain': [59], 'MS': [60, 177], 'Center': [61], 'University': [63], 'Colorado': [65], 'between': [66], 'January,': [67], '2010': [68], 'October,': [70], '2013': [71], 'were': [72, 86, 105, 143, 164, 281, 295], 'identified.': [73], 'Clinician-reported': [74], 'including': [76], 'demographics,': [77], 'disease': [78, 113, 120, 178], 'history,': [79], 'relapses,': [80], 'MRI': [81], 'outcomes,': [82], 'adverse': [84, 245], 'events(AEs),': [85], 'retrospectively': [87], 'collected.': [88], 'Primary': [89, 233], 'outcome': [90], 'was': [91], 'probability': [93], 'discontinuing': [95], 'drug': [96], 'within': [97], 'years.': [99, 152], 'Simple': [100], 'adjusted': [102, 210, 229], 'logistic': [103], 'regression': [104], 'used': [106], 'analysis': [109], 'controlling': [110], 'age,': [112], 'duration,': [114], 'type': [115], 'MS,': [117], 'gender,': [118], 'burden': [121], 'baseline': [123], '(missing,': [124], 'mild,': [125], 'moderate,': [126], 'severe)': [127], 'estimate': [129], 'differences': [130], 'in': [131, 290, 312, 374], 'primary': [133], 'outcome.': [134], 'Results:': [136], '271,': [138], '342': [139], '176': [141], 'patients': [142], 'evaluated': [144], 'on': [145], 'over': [150], 'had': [154, 174, 202, 222, 265, 273], 'mean': [156, 176], 'age': [157], '42.5(FTY),': [159], '45.8(DMF)': [160], '40.2(NTZ)': [162], 'years;': [163], 'predominantly': [165], 'female': [166], '(72.0%': [167], 'FTY;': [168], '69.6%': [169], 'DMF;': [170], '72.2%': [171], 'NTZ);': [172], 'duration': [179], '11': [181], 'years': [182, 294], 'all': [184], 'groups.': [185], 'At': [186], '≤24': [187, 217], 'months,': [188], '93(34.3%),': [189], '161(47.1%)': [190], '84(47.7%)': [192], 'discontinued': [193], 'NTZ,': [197], 'respectively.': [198], 'versus': [200, 220], 'an': [203, 223, 375], 'unadjusted': [204, 224], 'odds': [205], 'ratio(OR)': [206], '1.83(95%CI:1.24–2.70,p=0.002)': [208], 'OR': [211, 225, 230], '1.82(95%CI:1.21–2.72,p=0.004)': [213], 'months.': [218], '1.07(95%CI:0.75–1.55,p=0.700)': [227], '1.04(95%CI:0.70–1.52,p=0.859).': [232], 'reason': [234], 'discontinuation:': [236], '–': [238, 244], '+JCV': [239], 'antibodies(26.7%),': [240], 'events(17.0%': [246], '24.0%).': [248], 'Respectively': [249], '-': [255], '16(7.0%),': [256], '44(12.9%)': [257], '7(4.0%)': [259], 'relapsed,': [260], '24(12.9%),': [261], '25(9.8%)': [262], '6(5.7%)': [264], 'gadolinium-enhancing': [266], 'lesions': [267], '56(31.7%),': [269], '81(31.9%)': [270], '19(18.1%)': [272], 'new': [274], 'T2': [275], 'lesions.': [276], 'Conclusions:': [278], 'There': [280], 'fewer': [282], 'discontinuations': [283], 'vs.': [286], 'NTZ.': [287], 'Discontinuation': [288], 'first': [292], 'driven': [296], 'by': [297], 'AEs': [298], 'being': [300], 'positive': [301], 'JC': [303], 'virus': [304], 'antibodies.': [305], 'Further': [306], 'analyses': [307], 'will': [308], 'investigate': [309], 'superiority': [311], 'outcomes.': [314], 'Disclosure:': [317], 'Dr.': [319, 325, 335, 348, 354, 368, 382, 393, 447, 461], 'Vollmer': [320, 394], 'has': [321, 327, 337, 350, 356, 370, 384, 395, 449, 463], 'nothing': [322, 351], 'disclose.': [324, 353], 'Nair': [326, 336], 'received': [328, 338, 357, 371, 385, 396, 450, 464], 'personal': [329, 358, 372, 397, 451], 'compensation': [330, 359, 373, 398, 452], 'activities': [332, 361, 400], 'Astellas.': [334], 'research': [339, 386, 465], 'support': [340, 387, 466], 'from': [341, 388, 453, 467], 'Novartis,': [342, 363], 'Biogen,': [343, 456, 468], 'Gilead': [344], 'Sciences,': [345], 'Genentech.': [347], 'Sillau': [349], 'Corboy': [355, 369, 383], 'Genentech,': [364, 458], 'Prime': [366], 'Education.': [367], 'editorial': [376], 'capacity': [377], 'Neurology:': [379], 'Clinical': [380], 'Practice.': [381], 'Novartis': [389, 428], 'Sun': [391], 'Pharma.': [392], 'AbbVie;': [402], 'Alcimed,': [403], 'AAN,CB': [404], 'Partners,': [405], 'Capmeaels': [406], 'Rasford,': [408], 'Celestial': [409], 'Intas': [410], 'Pharmaceuticals': [411], 'LTD,': [412], 'Compass': [413], 'Learning,': [414], 'Genentech/Roche,': [415], 'Genzyme/Sanofi,': [416], 'Goodwin': [417], 'Procter,': [418], 'LLP,': [419], 'Guth': [420], 'Jackson': [421], 'Charitable': [422], 'Foundation,': [423], 'IMS': [424], 'Consulting': [425], 'Group,': [426], 'MedScape,': [427], 'Pharmaceuticals,': [429], 'Oxford': [430], 'Pharmagenesis,': [431], 'Patient': [432], 'Centered': [433], 'Outcomes': [434], 'Research': [435], 'Institute,': [436], 'Sommer': [437], 'Consulting,': [438], 'Teva': [439, 454], 'Neuroscience': [440], 'Xenoport': [442], 'Inc.': [443], 'consultant.': [446], 'Alvarez': [448, 462], 'Neuroscience,': [455], 'Genzyme,': [457], 'Novartis.': [460, 471], 'Teva,': [469]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2809097515', 'counts_by_year': [], 'updated_date': '2024-12-06T18:50:47.510474', 'created_date': '2018-06-29'}